2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pembrolizumab in High-risk Thyroid Cancerdifferentiated thyroid carcinomaRecruitingPhase 22026-04-20NCT05852223
Pembrolizumab in Locally Advanced Sinonasal Carcinomasinonasal undifferentiated carcinomaRecruitingPhase 22026-04-16NCT05925491